Title : Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Toward Prodrug-Nanomedicine Design.

Pub. Date : 2019 Apr 1

PMID : 30802065






11 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Toward Prodrug-Nanomedicine Design. Doxorubicin kallikrein related peptidase 3 Homo sapiens
2 It consists of doxorubicin (Dox) conjugated to a prostate specific antigen (PSA)-cleavable peptide that can be selectively activated by secreted PSA at the tumor site. Doxorubicin kallikrein related peptidase 3 Homo sapiens
3 It consists of doxorubicin (Dox) conjugated to a prostate specific antigen (PSA)-cleavable peptide that can be selectively activated by secreted PSA at the tumor site. Doxorubicin kallikrein related peptidase 3 Homo sapiens
4 It consists of doxorubicin (Dox) conjugated to a prostate specific antigen (PSA)-cleavable peptide that can be selectively activated by secreted PSA at the tumor site. Doxorubicin kallikrein related peptidase 3 Homo sapiens
5 It consists of doxorubicin (Dox) conjugated to a prostate specific antigen (PSA)-cleavable peptide that can be selectively activated by secreted PSA at the tumor site. Doxorubicin kallikrein related peptidase 3 Homo sapiens
6 It consists of doxorubicin (Dox) conjugated to a prostate specific antigen (PSA)-cleavable peptide that can be selectively activated by secreted PSA at the tumor site. Doxorubicin kallikrein related peptidase 3 Homo sapiens
7 It consists of doxorubicin (Dox) conjugated to a prostate specific antigen (PSA)-cleavable peptide that can be selectively activated by secreted PSA at the tumor site. Doxorubicin kallikrein related peptidase 3 Homo sapiens
8 In the present study, we have reported, for the first time, the intracellular activation of Dox-PSA, where Dox nuclear uptake was specific to C4-2B (PSA-expressing) cells, which agreed with the cytotoxicity studies. Doxorubicin kallikrein related peptidase 3 Homo sapiens
9 In the present study, we have reported, for the first time, the intracellular activation of Dox-PSA, where Dox nuclear uptake was specific to C4-2B (PSA-expressing) cells, which agreed with the cytotoxicity studies. Doxorubicin kallikrein related peptidase 3 Homo sapiens
10 This finding was confirmed by encapsulating Dox-PSA prodrug into pH-sensitive liposomes to enable prodrug intracellular release, followed by its enzymatic activation. Doxorubicin kallikrein related peptidase 3 Homo sapiens
11 Our approach could open the doors for novel Dox-PSA nanomedicines with higher safety and efficacy to treat advanced and metastatic prostate cancer. Doxorubicin kallikrein related peptidase 3 Homo sapiens